ZICHE, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 12.466
EU - Europa 9.969
AS - Asia 1.702
OC - Oceania 18
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
Totale 24.180
Nazione #
US - Stati Uniti d'America 12.447
GB - Regno Unito 3.429
IE - Irlanda 1.766
UA - Ucraina 1.237
CN - Cina 1.235
SE - Svezia 1.020
FR - Francia 592
IT - Italia 581
DE - Germania 579
FI - Finlandia 320
RU - Federazione Russa 286
SG - Singapore 147
VN - Vietnam 109
IN - India 97
TR - Turchia 75
ES - Italia 43
BE - Belgio 39
CA - Canada 17
AU - Australia 15
NL - Olanda 12
CZ - Repubblica Ceca 8
HK - Hong Kong 8
RO - Romania 8
BG - Bulgaria 7
AT - Austria 6
EU - Europa 6
PL - Polonia 6
GR - Grecia 5
EE - Estonia 4
IL - Israele 4
JP - Giappone 4
NG - Nigeria 4
DK - Danimarca 3
EG - Egitto 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BR - Brasile 2
CH - Svizzera 2
HR - Croazia 2
MA - Marocco 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IQ - Iraq 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MX - Messico 1
MZ - Mozambico 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 24.180
Città #
Southend 3.237
Fairfield 1.996
Dublin 1.753
Chandler 1.074
Ashburn 1.055
Jacksonville 1.008
Woodbridge 944
Houston 881
Seattle 795
Wilmington 782
Cambridge 683
Ann Arbor 464
Princeton 364
Nanjing 311
Beijing 232
Siena 198
Boardman 160
San Diego 151
Menlo Park 148
Nanchang 126
Helsinki 115
San Mateo 115
Dong Ket 108
Fremont 101
Singapore 86
Pune 81
Tianjin 75
Moscow 74
Shenyang 74
Kunming 64
Izmir 61
Hebei 53
Changsha 41
Brussels 39
Florence 39
Dearborn 37
Jinan 36
Málaga 36
Norwalk 35
Jiaxing 30
Falls Church 29
London 29
Lancaster 28
New York 27
Rome 27
Shanghai 27
Düsseldorf 26
Redwood City 26
Zhengzhou 25
San Francisco 24
Hangzhou 22
Ningbo 18
Taizhou 18
Changchun 17
Toronto 14
Lanzhou 12
Prato 12
Renton 12
Tappahannock 11
Guangzhou 10
Los Angeles 10
Amsterdam 9
Anguillara Sabazia 9
Mestre 9
Milan 9
Venezia 9
Kocaeli 8
Phoenix 8
Dallas 7
Hounslow 7
Melbourne 7
Sofia 7
Atlanta 6
Canberra 6
Chicago 6
Edinburgh 6
Falkenstein 6
Kilburn 6
Madrid 6
Washington 6
Delhi 5
Frankfurt am Main 5
Indiana 5
New Bedfont 5
Rende 5
Saint Petersburg 5
Vienna 5
Warsaw 5
Acton 4
Avezzano 4
Bonndorf 4
Clifton 4
Foiano della Chiana 4
Fuzhou 4
Hefei 4
Islington 4
Munich 4
Tallinn 4
Auckland 3
Bari 3
Totale 18.309
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 324
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 280
A fucose-containing O-glycoepitope on bovine and human nucleolin 221
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 220
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 210
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 199
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 187
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 186
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 185
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 179
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 177
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 176
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 174
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 174
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. 166
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 165
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 161
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 161
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 160
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 157
Studying vascular angiogenesis and senescence in zebrafish embryos 156
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 156
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects 154
The rabbit corneal pocket assay 152
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 151
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 151
Differential contribution of bradykinin receptors in angiogenesis 147
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 147
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 147
Assessing vascular senescence in zebrafish. 145
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 145
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 144
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 143
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 142
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 142
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 140
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 140
Divergent effects of quercetin conjugates on angiogenesis. 139
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells. 138
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 138
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 137
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 134
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases 134
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 132
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis. 129
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 128
In vitro and in vivo activation of endothelial cells by colony-stimulating factors 128
The corneal pocket assay 126
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 126
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 124
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers. 124
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 123
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 123
Analysis of the role of chemokines in angiogenesis 122
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 122
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk. 121
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. 121
NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins 121
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 120
Role of nitric oxide in the modulation of angiogenesis 119
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 119
The effect of thiorphan on release of sensory neuropeptides from guinea-pig cerebral venous sinuses 118
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 118
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth 118
Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium 117
In vitro and in vivo models to study chemokine regulation of angiogenesis 116
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 116
Pyridoxamine as inhibitor of the blood plasma benzylamine oxidase and other copper-containing amine oxidases 115
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability 115
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 115
Influence of lithium on mammary tumor growth in vivo 114
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 114
Gangliosides, copper ions and angiogenic capacity of adult tissues 114
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 114
Absence of PAF actions increases angiogenesis 113
Nitric oxide in tumor angiogenesis. 113
Thapsigargin inhibits the response to acetylcholine and substance P but does not interfere with the responses to endothelium-independent agents. 113
Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis. 113
Ceruloplasmin, copper ions, and angiogenesis. 113
Biological characterization of nanocomposite hydrogels 113
Vimentin expression influences flow dependent VASP phosphorylation and regulates cell migration and proliferation. 112
ETB receptors promote proliferation and migration of endothelial cells 112
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 112
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis 112
Copper-dependent amine oxidases in angiogenesis induced by prostaglandin E1 (PGE1) 112
Effects of substance P on mesenteric lymphatic contractility in the rat 110
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo 110
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. 110
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit 110
Constitutive and inducible nitric oxide synthase: role in angiogenesis 109
Nitric oxide and angiogenesis 109
Role of prostaglandin E1 and copper in angiogenesis 109
Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. 108
Angiogenesis and neoplastic progression in vitro. 108
Growth and motility of microvascular endothelium are modulated by the relative concentration of gangliosides in the medium. 107
The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture 107
Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium 107
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. 106
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways. 106
Hydrogen peroxide mediates endothelium-dependent dilation of coronary arterioles in obese rats on low carbohydrate diet. 106
Totale 13.776
Categoria #
all - tutte 75.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.873 0 193 411 933 487 388 427 766 428 406 104 330
2020/20214.100 156 447 91 396 181 567 139 650 537 288 313 335
2021/20222.848 188 395 153 350 122 120 134 122 105 328 247 584
2022/20233.828 249 272 499 593 388 783 51 291 411 69 127 95
2023/20242.375 115 50 155 189 63 696 836 56 3 26 16 170
2024/2025316 88 228 0 0 0 0 0 0 0 0 0 0
Totale 24.407